menu
    • menu

    Company profile for IACTA Pharmaceuticals

    NEW Drugs in Dev.: 3
    Evonik

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-01-12

    Virtual Booth

    Contact Supplier

    End-to-end drug development, specializing in high-potency softgels and liquids, providing global partners with a competitive advantage.

    Virtual Booth

    Contact Supplier

    Kewpie is your partner for Sodium Hyaluronate & Hyaluronic Acid// CEP, USDMF, KDMF & JDMF registered.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    IACTA Pharmaceuticals is an innovative ophthalmic company developing a portfolio of novel assets in large ocular markets, beginning with ocular pain and dry eye disease. IACTA Pharmaceuticals is an R&D focused company that is creating innovative treatment-opportunities in the ever-growing industry of ophthalmology and eye care. Using our wide range of expertise, we are able to identify new technologies and transform them into ...
    IACTA Pharmaceuticals is an innovative ophthalmic company developing a portfolio of novel assets in large ocular markets, beginning with ocular pain and dry eye disease. IACTA Pharmaceuticals is an R&D focused company that is creating innovative treatment-opportunities in the ever-growing industry of ophthalmology and eye care. Using our wide range of expertise, we are able to identify new technologies and transform them into beneficial treatments that can help many patients worldwide

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    IACTA PharmaceuticalsPuertoRico Flag
    Country
    Country
    Puerto Rico
    Address
    Address
    Street 1, Metro Office Park, Lot 6, Suite 204 Guaynabo, Puerto Rico 00968
    Telephone
    Telephone
    (858) 525 2047
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    http://iactapharma.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    IACTA Pharma Announces Expansion of Scientific Advisory Board
    IACTA Pharma Announces Expansion of Scientific Advisory Board

    29 Jun 2022

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20220629005104/en

    BUSINESSWIRE
    29 Jun 2022
    Share Share
    IACTA Pharmaceuticals to Present at Jefferies Healthcare Conference
    IACTA Pharmaceuticals to Present at Jefferies Healthcare Conference

    01 Jun 2022

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20220601005586/en

    BUSINESSWIRE
    01 Jun 2022
    Share Share
    IACTA, TALLC Collaborate to Utilize Novel SmartCelle Topical Delivery Technology
    IACTA, TALLC Collaborate to Utilize Novel SmartCelle Topical Delivery Technology

    15 Dec 2021

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20211215005180/en

    BUSINESSWIRE
    15 Dec 2021
    Share Share
    IACTA Pharmaceuticals Receives U.S. Department of Defense Funding of $1 M
    IACTA Pharmaceuticals Receives U.S. Department of Defense Funding of $1 M

    28 Oct 2021

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20211028005201/en/IACTA-Pharmaceuticals-Receives-U.S.-Department-of-Defense-Funding-of-1-Million-to-Conduct-Preclinical-Studies-of-IC-800-to-Treat-Pain-Relief-for-Eye-Injury/?feedref=JjAwJuNHiystnCoBq_hl-RLXHJgazfQJNuOVHefdHP-D8R-QU5o2AvY8bhI9uvWSD8DYIYv4TIC1g1u0AKcacnnViVjtb72bOP4-4nHK5ieT3WxPE8m_kWI77F87CseT

    BUSINESSWIRE
    28 Oct 2021
    Share Share
    IACTA Pharmaceuticals Appoints Yogesh Bahl as Chief Financial Officer
    IACTA Pharmaceuticals Appoints Yogesh Bahl as Chief Financial Officer

    27 Jul 2021

    // PR NEWSWIRE

    https://www.businesswire.com/news/home/20210727005213/en

    PR NEWSWIRE
    27 Jul 2021
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search